DATE: July 29, 2020
TIME: 9:00am PDT, 12:009m EDT, 6:00pm CEST
Hepatitis C infection, once a formidable enemy, is now a curable disease. Dramatic advances in antiviral therapies have launched a new era in how hepatitis C is treated and in turn have significantly improved the prognosis once an infection is identified. Unfortunately, many individuals today who are infected with hepatitis C are completely unaware of infection status; it is estimated that only 20% of cases worldwide are diagnosed. Only when individuals are tested and diagnosed with a hepatitis C virus (HCV) infection can they be treated and reap the benefits of these therapeutic innovations. Bridging the gap between unaware and diagnosed can make huge differences in a patient’s long-term prognosis.
Webinars will be available for unlimited on-demand viewing after live event.
LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.